GlaxoSmithKline (GSK) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

GSK GlaxoSmithKline

Watchlist

38.370
-1.080-2.74%

Close Oct 3 16:00 ET

38.110
-0.260-0.68%

Pre 07:00 ET

78.26BMarket Cap14.98P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Top Gap Ups and Downs on Thursday: NVDA, ACN, BHP and More
Moomoo News18:00 ET · Markets
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
MT NewswiresOct 3 11:14 ET
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More
PR NewswireOct 3 08:30 ET
J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)
TipRanksOct 3 01:55 ET · Ratings
Express News | GSK : Jefferies Cuts Target Price to $53 From $54
ReutersOct 2 23:22 ET
Pfizer Cuts Haleon Stake in $3.3B Share Sale
Seeking AlphaOct 1 06:56 ET

Comments

70205719

Yesterday 02:47

$GlaxoSmithKline (GSK.US)$ down to 37-38?

CNNT

Sep 19 04:26

50bp rate cut, what is my strategy?

I feel that this rate cut against an uncertain recessionary and un/under-employment backdrop, on top other bad govermental policies = volatility. To add to this, there is too much hot money in the market, not just from US investors/ traders, but from all over the world, further contributing to the chaos.
My current strategy is defensive.
1) 50% of my portfolio is high dividend stock such as:
$Stellantis NV (STLA.US)$
$GlaxoSmithKline (GSK.US)$
$Ecopetrol (EC.US)$
...

Aggressive 50bp rate cut: How long will the market frenzy last?

Jsmooth420365

Sep 7 01:58

$GlaxoSmithKline (GSK.US)$ 👀

CNNT

Aug 26 11:10

Post #10 - Aug P&L sharing

I have 10% (value) leveraged ETFs just to be more risk-taking. The rest are old fashion, mostly non-tech, consistent dividend-paying stocks.

Share Your Profit/Loss

Meltyy

Aug 6 02:59

📅 FDA PDUFA Update…

🚨 This Week’s PDUFA:
$Humacyte (HUMA.US)$ : 🤔
⇨ Human Acellular Vessel (HAV)™
‣ Vascular Trauma
‣ PDUFA: 8/10/24 (BLA)
🗓️ Last Week’s AdCom & PDUFAs:
$Zevra Therapeutics (ZVRA.US)$ : Favorable AdCom 👍
🗳️ 11-5 votes in favor
⇨ Arimoclomol
‣ Niemann-Pick disease type C
‣ AdCom: 8/2/24 (NDA)
$Adaptimmune Therapeutics (ADAP.US)$ : Approved 🎉
⇨ TECELRA (afamitresgene autoleucel)
‣ Synovial sarcoma
‣ PDUFA: 8/4/24 (BLA)
$GlaxoSmithKline (GSK.US)$ : Approved 🎉
⇨ Jemperli
‣ Endometria...